XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical Oncology.
Duran AO, Karaca H, Besiroglu M, Bayoglu IV, Menekse S, Yapici HS, Yazilitas D, Bahceci A, Uysal M, Sevinc A, Hacibekiroglu I, Aksoy A, Tanriverdi O, Arpaci E, Inanc M, Dane F, Ozkan M.
Duran AO, et al. Among authors: hacibekiroglu i.
Asian Pac J Cancer Prev. 2014;15(23):10375-9. doi: 10.7314/apjcp.2014.15.23.10375.
Asian Pac J Cancer Prev. 2014.
PMID: 25556478
Free article.